My site

NGELHEIM, Germany and INDIANAPOLIS, US. - Tuesday, June 17th 2014 [ME NewsWire]

    Phase III data from two clinical trials presented at the American Diabetes Association's 74th Scientific Sessions®
    Added to metformin, empagliflozin demonstrated significantly greater reductions in blood glucose and body weight versus glimepiride, in a two-year study
    Added to multiple daily insulin injections in obese adults on high insulin doses, empagliflozin significantly reduced blood glucose and body weight with lower insulin doses compared to placebo

(BUSINESS WIRE) For Non-U.S. and Non-U.K. Media

Boehringer Ingelheim and Eli Lilly and Company presented results of two Phase III clinical trials studying the efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in adults with Type 2 Diabetes (T2D) at the American Diabetes Association's 74th Scientific Sessions&r ... Read more »

Matthew McCormick to Oversee Company’s Tank Water Project in Japan

IRVINE, Calif. - Monday, June 16th 2014 [ME NewsWire]

(BUSINESS WIRE)-- Kurion, Inc., an innovator in nuclear and hazardous waste management, announced the appointment of Matthew McCormick as Project Director. McCormick previously oversaw the Department of Energy’s (DOE) multi-billion dollar cleanup at the Hanford nuclear waste site, a role that capped a 32-year career in public service. Beginning in July, McCormick will oversee deployment of the new Kurion Mobile Processing System (KMPS) at the Fukushima Daiichi Nuclear Power Plant.

“I am honored to welcome Matt to the Kurion team,” said John Raymont, Kurion founder and president. “Matt brings a tremendous level of senior project and program management expertise that will immediately benefit our work at Fukushima.”

Raymont continued, “Matt will be responsible for the commissioning and operatio ... Read more »

CLARENCE, N.Y. - Monday, June 16th 2014 [ME NewsWire]

(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company will join the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes when Russell Investments (Russell) reconstitutes its U.S. and global equity indexes on June 27, 2014. Russell’s announcement of its annual reconstitution of these Russell indexes, which included 22nd Century Group, was listed on the Russell website on Friday, June 13, 2014, after the U.S. stock market closed.

“We are pleased to be added to various Russell Indexes. Our inclusion will generate further interest in the Company’s stock among those investors in the investment community who may be less familiar with 22nd Century Group,” stated Joseph Pandolfino, the Company’s Founder and CEO. He added, “One goal of 22nd Century Group’s management is to be included in the Russell 1000 Index within 3 years ... Read more »

Attendance Increases 29 Per Cent Over the 2013 Event

LONDON - Monday, June 16th 2014 [ME NewsWire]

Mobile Asia Expo 2014

(BUSINESS WIRE)-- The GSMA today reported that more than 26,000* unique visitors from 93 countries and territories attended the 2014 Mobile Asia Expo, held 11-13 June in Shanghai. The three-day conference and exhibition attracted executives from the industry’s largest and most influential mobile operators, device makers, equipment providers, software companies and Internet companies, as well as technology-savvy consumers. The conference programme drew more than 3,000 attendees, with more than 55 per cent of delegates holding C-level positions, including over 150 CEOs.

“Our third Mobile Asia Expo was a resounding success and was our largest-ever mobile industry event in Asia,” said John Hoffman, CEO, GSMA Ltd. “The significant increase in attendees illustrates the continued and growing interest in mobile techn ... Read more »

INGELHEIM, Germany - Monday, June 16th 2014 [ME NewsWire]

(BUSINESS WIRE)-- For media outside of the US/UK only

Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old.1 For older patients who receive chemotherapy, the median survival is less than a year.2 Even though AML is considered rare, it accounts for around 18,860 new cases and 10,000 deaths in the US each year and is the most frequent cause of leukaemia-related deaths.3

    Only 1 in 3 (36%) of people have heard of Acute Myeloid Leukaemia (AML), reveals survey of 2,520 people from across Europe.4
    Awareness varied between the 5 countries surveyed: Italy demonstrated the highest awareness of AML (53%) and France the lowest (24%).4
    An overwhelming majority (67%)4 believed leukaemia to be a ‘treatable’ form of cancer. However in the case of AML, prognosis is considered poor ... Read more »